Literature DB >> 2524191

Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania.

T B McNeely1, G Rosen, M V Londner, S J Turco.   

Abstract

Fragments of the lipophosphoglycan of Leishmania donovani were generated by phospholipase C digestion and mild acid hydrolysis. The fragments were purified and examined for inhibitory activity on protein kinase C isolated from rat brains. On a molar basis, the 1-O-alkylglycerol portion of LPG exhibited the most inhibitory activity, whereas the carbohydrate domain was not as effective. In addition, several glycolipid antigens from L. major, which contain short carbohydrate chains attached to phosphatidylinositol, were also efficient inhibitors of the enzyme. These results are consistent with the hypothesis that protein kinase C may be a key target for the parasites to overcome within host macrophages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524191      PMCID: PMC1138552          DOI: 10.1042/bj2590601

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Proposal for a function of the Leishmania donovani lipophosphoglycan.

Authors:  S J Turco
Journal:  Biochem Soc Trans       Date:  1988-06       Impact factor: 5.407

3.  Leishmania major: glycolipid antigens recognized by immune human sera.

Authors:  G Rosen; M V Londner; D Sevlever; C L Greenblatt
Journal:  Mol Biochem Parasitol       Date:  1988-01-01       Impact factor: 1.759

4.  Alkyl-linked diglycerides inhibit protein kinase C activation by diacylglycerols.

Authors:  L W Daniel; G W Small; J D Schmitt; C J Marasco; K Ishaq; C Piantadosi
Journal:  Biochem Biophys Res Commun       Date:  1988-02-29       Impact factor: 3.575

5.  Activation of protein kinase C in neutrophil cytoplasts. Localization of protein substrates and possible relationship with stimulus-response coupling.

Authors:  R Gennaro; C Florio; D Romeo
Journal:  FEBS Lett       Date:  1985-01-28       Impact factor: 4.124

6.  Leishmanial excreted factor: protein-bound and free forms from promastigote cultures of Leishmania tropica and Leishmania donovani.

Authors:  G M Slutzky; J El-On; C L Greenblatt
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

7.  Cell surface lipophosphoglycan of Leishmania donovani.

Authors:  D L King; Y D Chang; S J Turco
Journal:  Mol Biochem Parasitol       Date:  1987-05       Impact factor: 1.759

8.  Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan.

Authors:  P A Orlandi; S J Turco
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

9.  Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycan.

Authors:  S J Turco; S R Hull; P A Orlandi; S D Shepherd; S W Homans; R A Dwek; T W Rademacher
Journal:  Biochemistry       Date:  1987-09-22       Impact factor: 3.162

10.  Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor.

Authors:  M J McConville; A Bacic; G F Mitchell; E Handman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  30 in total

1.  Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.

Authors:  N Genois; B Barbeau; M Olivier; M J Tremblay
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Effect of glycosphingolipids purified from Leishmania (Leishmania) amazonensis amastigotes on human peripheral lymphocytes.

Authors:  Selma Giorgio; Marcia Regina M Santos; Anita H Straus; Helio K Takahashi; Clara Lúcia Barbiéri
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

3.  Structural analysis of a glycosylphosphatidylinositol glycolipid of Leishmania donovani.

Authors:  D Sevlever; P Påhlsson; G Rosen; B Nilsson; M V Londner
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

4.  Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis.

Authors:  Kai Zhang; Fong-Fu Hsu; David A Scott; Roberto Docampo; John Turk; Stephen M Beverley
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

5.  Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani.

Authors:  J R Giorgione; S J Turco; R M Epand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 6.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 7.  The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes.

Authors:  M J McConville; M A Ferguson
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

8.  The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts.

Authors:  Gerald F Späth; L A Garraway; Salvatore J Turco; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

9.  Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages.

Authors:  L Proudfoot; A V Nikolaev; G J Feng; W Q Wei; M A Ferguson; J S Brimacombe; F Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 10.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.